Under review

review analysis report
The ACCC has launched a review into the proposed merger of Arrow and Apotex Early last month, Arrow Pharmaceuticals and Apotex announced a proposed merger of their Australian and New Zealand generic pharmaceutical and OTC operations. In a statement, the two companies said the move was still subject to several conditions, including ACCC approval and

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous 'Australian products only'
Next Man caught with 'bucketloads' of drugs